Title of article :
Combined use of 123I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): A 2-year follow-up study
Author/Authors :
Kim، نويسنده , , Joong-Seok and Oh، نويسنده , , Yoon-Sang and Kim، نويسنده , , Yeong-In and Yang، نويسنده , , Dong-Won and Chung، نويسنده , , Yong-An and You، نويسنده , , Ie-Ryung and Lee، نويسنده , , Kwang-Soo، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2013
Abstract :
DIP is a heterogeneous clinical syndrome; some patients develop persistent and worsening of parkinsonian symptoms after discontinuation of the offending drug, or Parkinsonʹs disease (PD) reappears later after a full remission from DIP. However, it is diff
Keywords :
Preclinical Parkinsonיs disease , Dopamine transporter , Scintigraphy , Cardiac 123I-metaiodobenzylguanidine , Drug-induced Parkinsonism , Positron emission tomography
Journal title :
Archives of Gerontology and Geriatrics
Journal title :
Archives of Gerontology and Geriatrics
